Clinical Trials · NCT01508923
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 17
- Start date
- May 2001
- Locations
- 1 site, Denmark
- Primary endpoint
- 24-hour glucose profiles after three fixed meals